Therapy of Refractory Rheumatoid Arthritis
Lin Xing
Abstract
Lin Xing
Abstract
The definition of rheumatoid arthritis was introduced,the potential cause of its refractoricity was analyzed,and its medication strategy was elaborated,including increasing the dose of disease modifying antirheumatic drugs(DMARD),conbination therapy with multipul DMARD,such as methotrexate,sulfasalazine,hydroxychloraquine,adding cortex hormone,using new immune inhibitor-leflunomide,and biological agents such as TNF blocking agents.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The definition of rheumatoid arthritis was introduced,the potential cause of its refractoricity was analyzed,and its medication strategy was elaborated,including increasing the dose of disease modifying antirheumatic drugs(DMARD),conbination therapy with multipul DMARD,such as methotrexate,sulfasalazine,hydroxychloraquine,adding cortex hormone,using new immune inhibitor-leflunomide,and biological agents such as TNF blocking agents.
Key concepts: Leflunomide, Medicine, Sulfasalazine, Rheumatoid arthritis, Methotrexate, Antirheumatic drugs, Refractory (planetary science), Infliximab